Shanxi Sequoia Co. is engaged in biomedical R&D with a focus on Taxol. It owns thousands of acres of yew trees in Shanxi. Cardium Therapeutics has its focus on the treatment of cardiovascular disease and vascular regeneration, including wound healing and tissue engineering.
China Bio news release, March 6, 2014
Shanxi Sequoia Pharmacuetical Co. acquires US Cardium Therapeutics, San Diego.